Lanean...
In Vivo Base Editing of PCSK9 as a Therapeutic Alternative to Genome Editing
OBJECTIVE: High-efficiency genome editing to disrupt therapeutic target genes such as PCSK9 has been demonstrated in preclinical animal models, but there are safety concerns due to the unpredictable nature of cellular repair of double-strand breaks, as well as off-target mutagenesis. Moreover, preci...
Gorde:
| Argitaratua izan da: | Arterioscler Thromb Vasc Biol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5570639/ https://ncbi.nlm.nih.gov/pubmed/28751571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.117.309881 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|